Synopsis of recent research by authors named "Marc Friedman"
- Research by Marc Friedman primarily focuses on advancements in treatment modalities and biomarker assessments for liver-related cancers, particularly hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA).
- Recent studies include the development of a biomarker index for evaluating HCC treatment responses and examining disparities in curative treatments for early stage iCCA, highlighting the effectiveness of various treatment approaches and patient outcomes.
- Furthermore, his work investigates the combination of immunotherapy and transarterial radioembolization for advanced HCC, as well as the therapeutic comparisons of transarterial radioembolization versus systemic therapies for HCC with macrovascular invasion, emphasizing the importance of tailored treatment strategies for cancer patients.
